AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT programXuebiao Wu, Chenfang Dong, Mengjie Wang et al.|The Journal of Experimental Medicine|2017Cited by 171
Longevity biotechnology: bridging AI, biomarkers, geroscience and clinical applications for healthy longevityGil Blander, Qiang Fu, Dominika Wilczok et al.|Aging|2024Cited by 38
Anti-Tumor Necrosis Factor Receptor 2 Antibody Combined With Anti-PD-L1 Therapy Exerts Robust Antitumor Effects in Breast CancerQiang Fu, Wei Zhong|Frontiers in Cell and Developmental Biology|2021Cited by 11